ClinicalTrials.Veeva

Menu

The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy

S

Shahid Beheshti University of Medical Sciences

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Diabetic Retinopathy

Treatments

Drug: Triamcinolone

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

In this study, regressed proliferative diabetic retinopathy, very severe, severe and moderate non-prolifrative diabetic retinopathy patients who were going to have a cataract surgery, underwent a complete eye examination, OCT, FAG and color photography 2 weeks prior to their operation. All patients divided in two: 1) control group (Phyco,PCIOL), 2) triamcinolone treatment group (Phaco with PCIOL+IVT). One month after surgery a complete eye examination will be done especially; IOP and endophthalmitis. A 6 month follow-up will be done for these two groups and diabetic retinopathy progression will be checked.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetic patients with non-proliferative diabetic retinopathy and regressed PDR

Exclusion criteria

  • Uncontrolled HTN
  • History of glaucoma
  • Active PDR
  • NVI
  • TRD
  • Any ophthalmic operation
  • Renal problem(cr>3)
  • CVA
  • Uveitis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 1 patient group

Triamcinolone
Experimental group
Description:
Injection of intravitreal Triamcinolone
Treatment:
Drug: Triamcinolone

Trial contacts and locations

3

Loading...

Central trial contact

Siamak Moradian, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems